IDP PHARMA
IDP Pharma is a drug discovery company that develops first-in-class medicines (New Chemical Entities) directed to a novel class of therapeutic targets, intrinsically disordered proteins (IDPs). They are currently focused on exploiting new mechanisms of action to treat cancer diseases. Multiple myeloma is one of their priorities. IDP Pharma's efforts are directed towards promoting a real shift in cancer therapies to improve the lives of patients. To this end, the company has built an extraordinary committed team of experts in the field, supported by a professional advisory board, including IDPs and diseases experts, and business professionals.
IDP PHARMA
Industry:
Biopharma Biotechnology Medical
Founded:
2015-01-01
Address:
Barcelona, Catalonia, Spain
Country:
Spain
Website Url:
http://www.idp-pharma.com
Total Employee:
1+
Status:
Active
Total Funding:
1.67 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt WordPress Apache Wordpress Plugins Sitelinks Search Box
Similar Organizations
Healx
Healx is an AI-powered, patient-inspired technology company, pioneering the next generation of drug discovery for rare diseases.
NGM Biopharmaceuticals
NGM Biopharmaceuticals is a drug discovery company developing biotherapeutics for the gastrointestinal endocrine system.
Numab
Numab is a biotechnology company that offers antibody-based therapeutics for the treatment of severe diseases.
Pharnext
Pharnext is a biopharmaceutical company engaged in the development of treatments for severe neurological diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Sunshine Biopharma
Sunshine Biopharma focuses on the research, development, and commercialization of drugs for the treatment of various forms of cancer.
Current Employees Featured
Founder
Official Site Inspections
http://www.idp-pharma.com Semrush global rank: 6.42 M Semrush visits lastest month: 1.03 K
- Host name: vxhca-38.srv.cat
- IP address: 134.0.14.240
- Location: Spain
- Latitude: 40.4172
- Longitude: -3.684
- Timezone: Europe/Madrid
More informations about "IDP Pharma"
IDP Pharma - Crunchbase Company Profile & Funding
IDP Pharma is a drug discovery company that develops first-in-class medicines (New Chemical Entities) directed to a novel class of therapeutic targets, intrinsically disordered proteins …See details»
IDP Discovery Pharma SL - Drug pipelines, Patents, Clinical
IDP-121 is IDP Pharma's lead asset using its proprietary intrametics â„¢ technology platform enabling inhibition and cellular degradation of intrinsically disordered proteins (IDPs) Targeting …See details»
IDP Pharma - Capital Cell
The Company. IDP Pharma is a clinical stage biotechnological company that develops therapies to treat incurable cancers. The company is exclusively focused on developing first time ever …See details»
IDP Pharma - LinkedIn
IDP Pharma is a drug discovery company that develops first-in-class medicines (New Chemical Entities) directed to a novel class of therapeutic targets, intrinsically disordered proteins (IDPs).See details»
IDP Pharma - Overview, News & Similar companies | ZoomInfo.com
Oct 26, 2023 IDP Pharma announces first patient dosed in a Phase 1/2 Clinical Trial of IDP-121, a direct cMyc protein inhibitor and degrader IDP-121 is IDP Pharma's lead asset using its …See details»
IDP Pharma - Products, Competitors, Financials, Employees, …
About IDP Pharma. IDP Pharma is a drug discovery company focused on developing first-in-class medicines for cancer treatment. The company's main offerings include breakthrough …See details»
IDP Pharma - VentureRadar
IDP Pharma is a drug discovery company that develops first-in-class medicines (New Chemical Entities) directed to a novel class of therapeutic targets, intrinsically disordered proteins …See details»
IDP Pharma - Craft
IDP Pharma has 5 employees at their 1 location and $1.7 m in total funding,. See insights on IDP Pharma including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
IDP Pharma - Company Profile - Tracxn
Oct 20, 2024 IDP Pharma - Drug discovery company that develops medicines directed towards intrinsically disordered proteins (IDPs) to treat multiple myeloma.. Founded by Santiago …See details»
IDP Pharma - Updates, News, Events, Signals & Triggers
IDP Pharma may be growing as it has recently announced the dosing of the first patient in a Phase 1/2 Clinical Trial for its drug IDP-121, which is a direct cMyc protein inhibitor. This …See details»
Idp Pharma | Qualifyze
IDP Pharma is a pharmaceutical research firm that focuses on creating pioneering medications, particularly New Chemical Entities. The organization is committed to pursuing an innovative …See details»
IDP Pharma signs a license option for IDP-602 with a specialized ...
IDP Pharma has entered into a licensed option with a USA based Biotech for IDP-602, a first in class drug targeting IDPs driving eye diseases. The company is responsible to develop IDP …See details»
IDP Pharma - Contacts, Employees, Board Members, Advisors
IDP Pharma has 4 current employee profiles, including CSO Laura Nevola. Contacts. Edit Contacts Section. Job Department. Protected Content. Operations. Non-Management …See details»
news - IDP PHARMA
IDP Pharma will present at the Annual Meeting of the American Association for Cancer Research (June 22-24) its first in. Bio€quity 2019 (May 20-21) abril 28, 2019 / news / admin Bio€quity …See details»
IDP-233 - Drug Targets, Indications, Patents - Synapse - Patsnap
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.See details»
Pipeline - IDP-Pharma
Through the INTRAMETICS platform, we developed IDP-601, a pioneering dual inhibitor of HIF-1 and HIF-2. IDP-601 is currently undergoing IND enabling studies, showing significant promise …See details»
Pharma Intelligent Document Processing Report - Acodis
2023 Pharma IDP Report. Learn how industry leaders in Pharma are fueling new AI initiatives and increasing process efficiency with Intelligent Document Processing (IDP). Questions …See details»
Efficacy and safety of tezepelumab versus placebo in adults with ...
1 day ago A significant reduction was not observed in the annualised rate of moderate or severe COPD exacerbations with tezepelumab versus placebo. Further studies are required to …See details»
First patient dosed in a Phase 1/2 Clinical Trial of IDP ... - IDP-Pharma
Barcelona, Spain, October 26th 2023 — IDP Pharma, a clinical-stage biotechnology company pioneering the development of drugs that directly engage and degrade intrinsically disordered …See details»